Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Studies Underscore Doctor, Patient Burden of Part B Prior Authorization
Sep 24 2025
•
By
Lauren Flynn Kelly
Advocates have not been able to convince CMS to reverse a ban on step therapy.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Medicare
More from United States